JOSEPHINE KALLAH: Open Payments
NPI 1063287894 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 48 payments from 14 companies in 2025. Trend: 2023 $37 · 2024 $759 · 2025 $986
Food & beverage: $886Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $193 |
| GENZYME CORPORATION | 3 | $167 |
| ABBVIE INC. | 11 | $155 |
| Galderma Laboratories, L.P. | 4 | $66 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Organon LLC | 5 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Botanix SB Inc | 3 | $55 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $51 |
| PFIZER INC. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Zoryve, COSENTYX, SOFDRA, VTAMA, Cabtreo.
Industry payments across NJ — which companies pay providers there.
